Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hyuga Primary Care Co., Ltd. (7133:JPX), powered by AI.
Hyuga Primary Care Co., Ltd. is currently trading at ¥1,021. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Hyuga Primary Care Co., Ltd. on Alpha Lenz.
Hyuga Primary Care Co., Ltd.'s P/E ratio is 10.1.
“Hyuga Primary Care Co., Ltd. trades at a P/E of 10.1 (undervalued) with strong ROE of 35.8%. 3Y revenue CAGR of 20.0% highlights clear growth momentum.”
Ask for details →Hyuga Primary Care Co., Ltd. is a health care company primarily engaged in the provision of home medical care services in Japan. Its main purpose is to support the health and well-being of patients by delivering essential medical supplies and services directly to their homes. The company plays a crucial role in the medical industry by offering comprehensive home care solutions, which include the supply of nursing and care products, as well as the distribution of pharmaceuticals and medical equipment to patients who require long-term care at home. Hyuga Primary Care Co., Ltd. is vital to the healthcare sector, especially in Japan’s aging population context, where the demand for home-based medical care is increasing. The company’s operation is significant in the market as it not only facilitates access to necessary medical care for patients unable to visit hospitals but also helps alleviate the burden on traditional healthcare facilities. As a key player in the home medical care service field, Hyuga Primary Care Co., Ltd. contributes to the transformation and sustainability of the healthcare ecosystem by enhancing the delivery and accessibility of healthcare services.
“Hyuga Primary Care Co., Ltd. trades at a P/E of 10.1 (undervalued) with strong ROE of 35.8%. 3Y revenue CAGR of 20.0% highlights clear growth momentum.”
Ask for details →Hyuga Primary Care Co., Ltd. (ticker: 7133) is a company listed on JPX in the Healthcare sector (Medical Care Facilities). It has approximately 708 employees. Market cap is $7.3B.
The current price is 1,021 with a P/E ratio of 10.1x and P/B of 3.06x.
ROE is 35.82% and operating margin is 10.53%. Annual revenue is $10.0B.